Pregnancy and COVID-19
Policy and Strategy
- DOI
- 10.2991/ahsr.k.220206.059How to use a DOI?
- Keywords
- Pregnancy; Screening; Coronavirus; COVID-19
- Abstract
COVID-19 has led to a global emergency because of its infectivity to the general population, especially the vulnerable population, pregnant women. Changes in the immune system of pregnant women made them more vulnerable to developing adverse complications COVID-19. This study evaluates pregnant women with COVID-19 hospitalized in RS Universitas Mataram. We retrospectively collected the data from 89 pregnant patients who confirmed COVID-19 on RT-PCR between May and December 2020 in Universitas Mataram Hospital. The age range was 19-42 years, predominantly 26-30 years (33.7%). Most of the clinical manifestation was asymptomatic (77.04%), which projected an urgency to implement health protocol more disciplined manner. Most of them were in the 3rd trimester (85.39%). It may be related to the COVID-19 screening policy that required expecting mothers to be screened for COVID-19 before proceeding into any obstetric treatment and/or procedure. Several policies can be implemented to protect pregnant women who are a vulnerable group. Screening for COVID-19 can be carried out every trimester of pregnancy despite whether or not the symptom is present because pregnant women are more likely to be asymptomatic carriers. Therefore, early case findings can prevent massive transmission.
- Copyright
- © 2022 The Authors. Published by Atlantis Press International B.V.
- Open Access
- This is an open access article under the CC BY-NC license.
Cite this article
TY - CONF AU - Ario Danianto AU - Putu Diah Ananda Putri Atmaja AU - Muhammad Rizkinov Jumsa AU - Intan Wahyu Lasiaprillianty AU - Meilisva Audila Anggraini PY - 2022 DA - 2022/02/21 TI - Pregnancy and COVID-19 BT - Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021) PB - Atlantis Press SP - 319 EP - 321 SN - 2468-5739 UR - https://doi.org/10.2991/ahsr.k.220206.059 DO - 10.2991/ahsr.k.220206.059 ID - Danianto2022 ER -